Related Experiment Video
Updated: Dec 30, 2025

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
9.6K
Fair data for next-generation management of multiple sclerosis.
1Biomedical Research Institute, Hasselt University and School of Life Sciences, Transnationale Universiteit Limburg, Diepenbeek, Belgium.
Summary
Precision medicine for multiple sclerosis (MS) requires integrating diverse data. Making data FAIR (Findable, Accessible, Interoperable, Reusable) is key to personalized MS management and treatment strategies.
Area of Science:
- Neuroscience and Neurology
- Biomedical Informatics
- Genetics and Environmental Health
Background:
- Multiple sclerosis (MS) is a heterogeneous central nervous system disease characterized by variable clinical expressions and treatment responses.
- Current population-based management approaches for MS are insufficient, necessitating a shift towards individualized, personalized, and precision-level care.
- The clinical heterogeneity of MS is influenced by a complex interplay of genetic background and environmental factors.
Purpose of the Study:
- To outline a novel method for revolutionizing multiple sclerosis (MS) management towards a personalized, individualized, and precision-medicine approach.
- To highlight the critical role of FAIR data principles in achieving advanced insights and tailored treatments for MS patients.
Main Methods:
- The study proposes a method centered on the FAIR data principles (Findable, Accessible, Interoperable, Reusable) to overcome current data integration challenges.
- Addresses limitations of existing observational databases and IT platforms that hinder comprehensive data utilization for MS research and clinical practice.
Main Results:
- The proposed method aims to enable the integration of extensive, diverse datasets required for deep insights into individual MS cases.
- Facilitates a transition from generalized to highly specific patient management strategies based on comprehensive data analysis.
Conclusions:
- Implementing FAIR data principles is essential for advancing multiple sclerosis (MS) management to a personalized and precision level.
- This approach promises to enhance clinical follow-up, optimize multidisciplinary treatment strategies, and improve patient outcomes in MS.
Related Concept Videos
Atherosclerosis III: Management
280
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
280
Myasthenia Gravis: Overview and Treatment
2.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K

